The advertisement promotes COSELA (trilaciclib), a medication indicated to reduce chemotherapy-induced myelosuppression in adult patients undergoing treatment for extensive-stage small cell lung cancer.
Creative Information
| CID: | 48a6de38-593d-4604-862f-595f4b144ef3 |
| CRID: | 82_6677-898961 |
| Domain: | cosela.com |
| Seat: | PP |
| Size: | 300x250 |
| Bid: | $31.54 |
| Timestamp: | 2/2/2026, 3:24:30 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 2/2/2026, 3:24:58 AM | 4.50s | |
| adomain_analysis | success | 2/2/2026, 3:24:57 AM | 2.62s | |
| adomain_capture | success | 2/2/2026, 3:24:54 AM | 0.11s | |
| ad_render | success | 2/2/2026, 3:24:53 AM | 22.52s | |
| brand_mapping | success | 2/2/2026, 3:24:47 AM | 4.33s | |
Analysis Results
Ad Format: banner
Brands: COSELA
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 378.86 KB | ||||||||||||||||||||||
| Render Time: | 7.26 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 378.86 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives

